TABLE 3

Patient feature comparison for matched and unmatched patients in the registry dataset (n=32 036)

LUCADA and registry merged patients from 132 trustsLUCADA and registry unmerged patients from 132 trusts
Patients26 0016035
Sex
 Female11 990 (46%)2867 (48%)
 Male14 011 (54%)3168 (52%)
Age years
 <656032 (23%)1287 (21)
 65–8014 249 (55%)3023 (50)
 >805720 (22%)1725 (29)
Performance status
 03816 (15%)394 (7%)
 16550 (25%)639 (11%)
 24025 (15%)342 (6%)
 33553 (14%)384 (6%)
 41152 (4%)131 (2%)
 Missing6905 (27%)4145 (69%)
Stage
 IA2190 (8%)502 (8%)
 IB1836 (7%)271 (4%)
 IIA1096 (4%)184 (3%)
 IIB1018 (4%)131 (2%)
 IIIA3267 (13%)385 (6%)
 IIIB2353 (9%)230 (4%)
 IV12 699 (49%)2443 (41%)
 Missing1542 (6%)1889 (31%)
Lung cancer type
 Small cell2975 (11%)382 (6%)
 Carcinoid189 (1%)98 (2%)
 Nonsmall cell22 837 (88%)5555 (92%)
Surgery
 No21 825 (84%)5252 (87%)
 Yes4176 (16%)783 (13%)
Chemotherapy
 No17 226 (66%)5031 (83%)
 Yes8775 (34%)1004 (17%)
External-beam radiotherapy
 No18 262 (70%)5198 (86%)
 Yes7739 (30%)837 (14%)
Brachytherapy
 No25 967 (99.9%)6026 (99.9%)
 Yes34 (0.1%)9 (0.1%)

LUCADA: Lung Cancer Data.